Youth Nicotine Use: A Growing Public Health Concern

Nov.25.2022
Youth Nicotine Use: A Growing Public Health Concern
Teenagers in the US are increasingly using e-cigarettes and flavored tobacco products, leading to concerns of nicotine addiction.

According to data from the Centers for Disease Control and Prevention, approximately 1,600 young people in this country will try their first cigarette each day.


According to the 2022 National Youth Tobacco Survey, "3.7% of middle and high school students - about 1 million in total - have tried combustible tobacco products such as cigars or cigarettes," reported Ken Alltucker of USA Today. This isn't even their most popular choice. Survey data shows that e-cigarettes are by far the most popular choice for school-age children. During the study period from January 18 to May 31, "nearly 3.1 million middle and high school students tried e-cigarettes or other tobacco products." Among adolescent e-cigarette users, "85% said they use flavored e-cigarettes, with over half using disposable e-cigarettes.


The number of people using very specific tobacco products is much higher among certain groups, and this is not a coincidence," said Matthew L. Myers, President of the non-profit organization, the Campaign for Tobacco-Free Kids. "This is directly related to the advertising positioning of the tobacco industry.


It is truly concerning that 3 million children are using these products," added Erika Sward, Assistant Vice President for National Advocacy at the American Lung Association.


Seasoning products have fueled this epidemic from the beginning," said Dennis Henigan, Vice President of Law and Regulatory Affairs for the Campaign for Tobacco-Free Kids, to USA Today.


Flavored electronic cigarettes are causing a new generation of Americans to become addicted to nicotine," wrote Margaret Foti, CEO of the American Association for Cancer Research, in a recent STAT news op-ed.


In the past decade, there has been a significant increase in the number of teenagers, young adults, and individuals who have never previously used tobacco products, using flavored electronic cigarettes and other electronic nicotine delivery systems, reaching its peak among high school students in 2019," said Forte. "While the use of these products saw a decline during the COVID-19 pandemic, their popularity is once again on the rise.


According to a report by USA Today, although the US Food and Drug Administration issued a ban in 2020 prohibiting the use of flavor cartridges in e-cigarettes that deliver nicotine, the industry seems to have found a way around this regulation by selling lab-made nicotine instead of tobacco-made nicotine. Earlier this year, the FDA warned synthetic nicotine manufacturers and retailers about the illegal sale and marketing of these products.


Swod warned that, "Until we address the root causes - wholesalers, manufacturers, and distributors - we will continue in this cycle" of young people vaping.


Foti wrote: "Prohibiting flavored (electronic nicotine delivery systems) products would be a powerful strategy for reducing their appeal to young people, and reducing the appeal of these products must be an urgent public health priority.


In late October, the American Cancer Society and the American Society of Clinical Oncology released an updated joint policy statement calling for urgent action to prevent further nicotine addiction. "It includes a ban on all flavored electronic nicotine delivery system products and strengthened regulatory enforcement," she added. The research cited by Foti suggests that young people who use these products are approximately three times more likely to start smoking traditional cigarettes than their peers who do not use them.


As cancer experts, we are increasingly concerned about the growing use of electronic nicotine delivery systems, as adolescents and young people who may not have used traditional tobacco products are now using these devices and risking addiction to nicotine, which in turn could lead to long-term use of combustible tobacco," she added.


According to an article on NewsForKids.net, a platform created by teachers to inform children about news, the problems caused by e-cigarettes could last a lifetime for those who have never smoked before. In the US, cigarettes and e-cigarettes can only be sold to adults, but many companies are attempting to lure young people into trying e-cigarettes by using flavors such as candy or cotton candy, making the e-liquid look like children's juice or candy. Therefore, many young people are starting to use e-cigarettes, believing them to be safe.


It is dangerous for young people's brain development to be exposed to nicotine. The Mayo Clinic states that for some individuals, any amount of tobacco use can quickly lead to nicotine addiction. This is the reality our children are facing.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in the translator's ability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan or foreign-related issues and statements.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10